187 related articles for article (PubMed ID: 36098244)
1. Immunophenotypic and molecular profile of cancer stem-cell markers in ex vivo canine transmissible venereal tumour (CTVT).
Grandi F; Miot HA; Rocha RM; Gomes CMS; Queiroz-Hazarbassanov N; Montoya-Florez LM; Cogliati B; Rocha NS
Vet Med Sci; 2022 Nov; 8(6):2297-2306. PubMed ID: 36098244
[TBL] [Abstract][Full Text] [Related]
2. Cell-mediated immunity and expression of MHC class I and class II molecules in dogs naturally infected by canine transmissible venereal tumor: Is there complete spontaneous regression outside the experimental CTVT?
do Prado Duzanski A; Flórez LMM; Fêo HB; Romagnoli GG; Kaneno R; Rocha NS
Res Vet Sci; 2022 Jul; 145():193-204. PubMed ID: 35240476
[TBL] [Abstract][Full Text] [Related]
3. Sex disparity in oronasal presentations of canine transmissible venereal tumour.
Strakova A; Baez-Ortega A; Wang J; Murchison EP
Vet Rec; 2022 Sep; 191(5):e1794. PubMed ID: 35781651
[TBL] [Abstract][Full Text] [Related]
4. Computerized Cytomorphometric and Cytomorphological Analysis of Canine Transmissible Venereal Tumours.
Setthawongsin C; Tangkawattana S; Rungsipipat A; Techangamsuwan S
J Comp Pathol; 2018 Aug; 163():18-22. PubMed ID: 30213369
[TBL] [Abstract][Full Text] [Related]
5. Identification of mitochondrial DNA transfer in canine transmissible venereal tumours obtained from dogs in Mexico.
Bautista-Gómez L; Martínez-Castañeda S
Mitochondrial DNA A DNA Mapp Seq Anal; 2017 Sep; 28(5):645-649. PubMed ID: 27159723
[TBL] [Abstract][Full Text] [Related]
6. Computer tomographic imaging in 4 dogs with primary nasal canine transmissible venereal tumor and differing cellular phenotype.
Ojeda J; Mieres M; Soto F; Arnes V; Paredes E; Navarrete M
J Vet Intern Med; 2018 May; 32(3):1172-1177. PubMed ID: 29604101
[TBL] [Abstract][Full Text] [Related]
7. A retrospective study of canine transmissible venereal tumour in Grenada, West Indies.
Schectman SJ; Khanam A; Walters MND; Kirwan E; Sylvester WR; Khan FA
Vet Med Sci; 2022 May; 8(3):1008-1012. PubMed ID: 35238497
[TBL] [Abstract][Full Text] [Related]
8. Transmission of canine transmissible venereal tumour between two dogs in the UK.
Hayes AM; Schiavo L; Constantino-Casas F; Desmas I; Dobson J; Draper A; Elliot J; Genain MA; Wang J; Murchison EP
J Small Anim Pract; 2023 Sep; 64(9):590-594. PubMed ID: 36990106
[TBL] [Abstract][Full Text] [Related]
9. Effect of tumor infiltrating lymphocytes on the expression of MHC molecules in canine transmissible venereal tumor cells.
Hsiao YW; Liao KW; Hung SW; Chu RM
Vet Immunol Immunopathol; 2002 Aug; 87(1-2):19-27. PubMed ID: 12052339
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a genetic assay for canine transmissible venereal tumour diagnosis in Brazil.
Castro KF; Strakova A; Tinucci-Costa M; Murchison EP
Vet Comp Oncol; 2017 Jun; 15(2):615-618. PubMed ID: 27135875
[TBL] [Abstract][Full Text] [Related]
11. TP53 Polymorphisms allow for genetic sub-grouping of the canine transmissible venereal tumor.
Sánchez-Servín A; Martínez S; Córdova-Alarcon E; Fajardo R
J Vet Sci; 2009 Dec; 10(4):353-5. PubMed ID: 19934603
[TBL] [Abstract][Full Text] [Related]
12. Canine transmissible venereal tumor - From general to molecular characteristics: A review.
Faro TAS; de Oliveira EHC
Anim Genet; 2023 Feb; 54(1):82-89. PubMed ID: 36259378
[TBL] [Abstract][Full Text] [Related]
13. Heat shock proteins in canine transmissible venereal tumor.
Chu RM; Sun TJ; Yang HY; Wang DG; Liao KW; Chuang TF; Lin CH; Lee WC
Vet Immunol Immunopathol; 2001 Sep; 82(1-2):9-21. PubMed ID: 11557291
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and Management of an Oronasal Fistula Secondary to Nasal Transmissible Venereal Tumor in a Dog.
Thatcher G; Robat C; Bell C
J Vet Dent; 2020 Dec; 37(4):220-226. PubMed ID: 33719713
[TBL] [Abstract][Full Text] [Related]
15. Stromal cells and extracellular matrix components in spontaneous canine transmissible venereal tumour at different stages of growth.
Mukaratirwa S; Chimonyo M; Obwolo M; Gruys E; Nederbragt H
Histol Histopathol; 2004 Oct; 19(4):1117-23. PubMed ID: 15375754
[TBL] [Abstract][Full Text] [Related]
16. The changing global distribution and prevalence of canine transmissible venereal tumour.
Strakova A; Murchison EP
BMC Vet Res; 2014 Sep; 10():168. PubMed ID: 25186078
[TBL] [Abstract][Full Text] [Related]
17. The T963C mutation of TP53 gene does not participate in the clonal origin of canine TVT.
Vázquez-Mota N; Simón-Martínez J; Córdova-Alarcon E; Lagunes L; Fajardo R
Vet Res Commun; 2008 Feb; 32(2):187-91. PubMed ID: 17668284
[TBL] [Abstract][Full Text] [Related]
18. Canine transmissible venereal tumour: cytogenetic origin, immunophenotype, and immunobiology. A review.
Mukaratirwa S; Gruys E
Vet Q; 2003 Sep; 25(3):101-11. PubMed ID: 14535580
[TBL] [Abstract][Full Text] [Related]
19. Canine transmissible venereal tumour: a review.
Ganguly B; Das U; Das AK
Vet Comp Oncol; 2016 Mar; 14(1):1-12. PubMed ID: 23981098
[TBL] [Abstract][Full Text] [Related]
20. Autologous canine immunotherapy: short-time generated dendritic cells loaded with canine transmissible venereal tumor-whole lysate.
Franco-Molina MA; Ramos-Zayas Y; Coronado-Cerda EE; Mendoza-Gamboa E; Zapata-Benavides P; Santana-Krymskaya SE; Tamez-Guerra R; Rodríguez-Padilla C
Immunopharmacol Immunotoxicol; 2018 Oct; 40(5):437-443. PubMed ID: 30507311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
